​

Aldeyra Therapeutics (ALDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aldeyra Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$244.53K

Aldeyra Therapeutics Revenue by Period

Aldeyra Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Aldeyra Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aldeyra Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$244.53K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$392.62K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31$8.30M-100.00%
2017-12-31$24.12T100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31$4.01M-75.10%
2016-12-31$16.11M100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31--

Aldeyra Therapeutics generated $244.53K in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Aldeyra Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$508.82M$149.41M
ARDXArdelyx$333.62M$74.11M
TVTXTravere Therapeutics$233.18M$81.73M
TARSTarsus Pharmaceuticals$182.95M$78.33M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
PHATPhathom Pharmaceuticals$55.25M$28.52M
ETONEton Pharmaceuticals$39.01M$11.65M
LXRXLexicon Pharmaceuticals$31.08M$26.55M
IBRXImmunityBio$14.74M$16.52M
BLRXBioLineRx$4.80M$6.86M
XFORX4 Pharmaceuticals$2.56M$28.81M
LYRALyra Therapeutics$1.53M$209.00K
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
ETNB89bio--
MCRBSeres Therapeutics--
ALDXAldeyra Therapeutics-$244.53K
VRDNViridian Therapeutics-$72.00K
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
HOOKHOOKIPA Pharma--

ALDX Revenue FAQ

What is Aldeyra Therapeutics’s yearly revenue?

Aldeyra Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ALDX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Aldeyra Therapeutics’s quarterly revenue?

Aldeyra Therapeutics's quarterly revenue for Q4 2024 was $244.53K, a 100.00% increase from the previous quarter (Q3 2024), and a -37.72% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). ALDX's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Aldeyra Therapeutics’s revenue growth rate?

Aldeyra Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.